| Application no. and date | 01933328.5 (espacenet) (Federated) (European Patent Register), 20010511 | | Patent/reg. no. and date | DK/EP 1292321, 20111026 | | Publication date | 20030319 | | Priority no. and date | US 203758 P, 20000512 | | EP pub. no. and date |
EP 1292321 20030319 | | Effective date | | | Applicant/owner | NorthWest Biotherapeutics, Inc., 4800 Montgomery Lane, Suite 800
Bethesda. MD 20814, US | | Applicant ref. no. | P81110128DK00E | | Inventor | BOYNTON, Alton, L., 2420 274th Avenue N.E.
Redmond, WA 98053, US,
SALGALLER, Michael, L., 12517 80th Place N.E.
Kirkland, WA 98034, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 39/00 (2006.01) | | Title | Fremgangsmåde til at forøge klasse 1 præsentation af exogene antigener gennem humane dendritiske celler | | Int. application no. | US2001015428 | | Int. publication no. | WO2001087325 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
